微信公众号

官网二维码

中国癌症防治杂志 ›› 2025, Vol. 17 ›› Issue (4): 401-407.doi: 10.3969/j.issn.1674-5671.2025.04.01

• 新技术新方法专栏 •    下一篇

核酸适配体在癌症诊断及治疗应用中的研究进展

  

  1. 哈尔滨工程大学材料科学与化学工程学院
  • 出版日期:2025-08-25 发布日期:2025-09-11
  • 通讯作者: 盖世丽,E-mail:gaishili@hrbeu.edu.cn;丁鹤,E-mail:dinghe@hrbeu.edu.cn
  • 基金资助:
    国家自然科学基金面上项目(52272144)

Research progress on the application of aptamers in cancer diagnosis and therapy

  • Online:2025-08-25 Published:2025-09-11

摘要: 核酸适配体指通过指数富集的配体系统进化技术(systematic evolution of ligands by exponential enrichment, SELEX)筛选获得的单链DNA或RNA分子,具备特异性识别并结合金属离子、小分子、蛋白质、细胞等靶标特性。这类分子凭借低分子量、靶标范围广、合成便捷、低免疫原性和高稳定性等优势,在癌症领域展现出巨大的应用潜力。目前,核酸适配体被广泛应用于电化学、比色、荧光和化学发光等生物传感器技术领域,助力实现肿瘤标志物的精准检测,并提升癌症诊断工具的灵敏度。此外,核酸适配体通过靶向递送药物、阻断免疫检查点等方式为癌症治疗提供了新策略。本文系统综述了核酸适配体的基本特性及其在生物传感技术和癌症治疗应用的新进展。

关键词: 核酸适配体, 传感技术, 癌症, 检测, 诊断, 治疗

Abstract: Aptamers are single⁃stranded DNA or RNA molecules obtained through the systematic evolution of ligands by exponential enrichment (SELEX), exhibit high specificity in recognizing and binding to target molecules, including metal ions, small molecules, proteins, and cells. Aptamers offer several advantages, such as low molecular weight, a broad target range, ease of synthesis, low immunogenicity, and high stability, thereby demonstrating significant potential in cancer research. Currently, aptamers are widely used in biosensing technologies, including electrochemical, colorimetric, fluorescent, and chemiluminescent sensors, facilitating the highly specific detection of tumor biomarkers and enhancing the sensitivity of  diagnostic tools for cancer detection. Furthermore, aptamers present novel strategies for cancer therapy through mechanisms such as targeted drug delivery and immune checkpoint blockade. This article provides a systematic review of the fundamental characteristics of aptamers and their advancements in biosensing technology and cancer therapy applications.

Key words: Aptamer, Sensing technology, Cancer, Detection, Diagnosis, Therapy

中图分类号: 

  • R730